APO RESEARCH · REPORT
Insulin Pen
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Product & engineering
Understand the product.
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.
Selected research
Industry Growth & Trends
Global Insulin Pen Industry Growth and Trends Forecast to 2032
Market perspective
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.
EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.
Read the full market overview
The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.
Report Scope
This report provides a structured, data-driven view of the global Insulin Pen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Insulin Pen market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Pen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Pen.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Insulin Pen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Insulin Pen Market by Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Insulin Pen Segment by Type
Reusable Insulin Pen
Disposable Insulin Pen
Insulin Pen Segment by Application
Hospitals
Clinics
The Chemist's Shops
Insulin Pen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Pen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Insulin Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Insulin Pen
- Disposable Insulin Pen
Applications
- Hospitals
- Clinics
- The Chemist's Shops
Companies covered
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Insulin Pen Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Insulin Pen Sales Estimates and Forecasts (2021-2032)
- 1.3 Insulin Pen Market by Type
- 1.3.1 Reusable Insulin Pen
- 1.3.2 Disposable Insulin Pen
- 1.4 Global Insulin Pen Market Size by Type
- 1.4.1 Global Insulin Pen Market Size Overview by Type (2021-2032)
- 1.4.2 Global Insulin Pen Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Insulin Pen Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Insulin Pen Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Insulin Pen Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Insulin Pen Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Insulin Pen Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Insulin Pen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Insulin Pen Industry Trends
- 2.2 Insulin Pen Industry Drivers
- 2.3 Insulin Pen Industry Opportunities and Challenges
- 2.4 Insulin Pen Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Insulin Pen Revenue (2021-2026)
- 3.2 Global Top Players by Insulin Pen Sales (2021-2026)
- 3.3 Global Top Players by Insulin Pen Price (2021-2026)
- 3.4 Global Insulin Pen Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Insulin Pen Major Company Production Sites & Headquarters
- 3.6 Global Insulin Pen Company, Product Type & Application
- 3.7 Global Insulin Pen Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Insulin Pen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Insulin Pen Players Market Share by Revenue in 2025
- 3.8.3 2025 Insulin Pen Tier 1, Tier 2, and Tier 3
4 Insulin Pen Regional Status and Outlook
- 4.1 Global Insulin Pen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Insulin Pen Historic Market Size by Region
- 4.2.1 Global Insulin Pen Sales in Volume by Region (2021-2026)
- 4.2.2 Global Insulin Pen Sales in Value by Region (2021-2026)
- 4.2.3 Global Insulin Pen Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Insulin Pen Forecasted Market Size by Region
- 4.3.1 Global Insulin Pen Sales in Volume by Region (2027-2032)
- 4.3.2 Global Insulin Pen Sales in Value by Region (2027-2032)
- 4.3.3 Global Insulin Pen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Pen by Application
- 5.1 Insulin Pen Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 The Chemist's Shops
- 5.2 Global Insulin Pen Market Size by Application
- 5.2.1 Global Insulin Pen Market Size Overview by Application (2021-2032)
- 5.2.2 Global Insulin Pen Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Insulin Pen Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Insulin Pen Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Insulin Pen Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Insulin Pen Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Insulin Pen Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Insulin Pen Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Novo Nordisk
- 6.1.1 Novo Nordisk Company Information
- 6.1.2 Novo Nordisk Business Overview
- 6.1.3 Novo Nordisk Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Novo Nordisk Insulin Pen Product Portfolio
- 6.1.5 Novo Nordisk Recent Developments
- 6.2 Eli Lilly
- 6.2.1 Eli Lilly Company Information
- 6.2.2 Eli Lilly Business Overview
- 6.2.3 Eli Lilly Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Eli Lilly Insulin Pen Product Portfolio
- 6.2.5 Eli Lilly Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Insulin Pen Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 BD
- 6.4.1 BD Company Information
- 6.4.2 BD Business Overview
- 6.4.3 BD Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 BD Insulin Pen Product Portfolio
- 6.4.5 BD Recent Developments
- 6.5 Ypsomed Holding
- 6.5.1 Ypsomed Holding Company Information
- 6.5.2 Ypsomed Holding Business Overview
- 6.5.3 Ypsomed Holding Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ypsomed Holding Insulin Pen Product Portfolio
- 6.5.5 Ypsomed Holding Recent Developments
- 6.6 Dongbao
- 6.6.1 Dongbao Company Information
- 6.6.2 Dongbao Business Overview
- 6.6.3 Dongbao Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Dongbao Insulin Pen Product Portfolio
- 6.6.5 Dongbao Recent Developments
- 6.7 Owen Mumford
- 6.7.1 Owen Mumford Company Information
- 6.7.2 Owen Mumford Business Overview
- 6.7.3 Owen Mumford Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Owen Mumford Insulin Pen Product Portfolio
- 6.7.5 Owen Mumford Recent Developments
- 6.8 Ganlee
- 6.8.1 Ganlee Company Information
- 6.8.2 Ganlee Business Overview
- 6.8.3 Ganlee Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Ganlee Insulin Pen Product Portfolio
- 6.8.5 Ganlee Recent Developments
7 North America by Country
- 7.1 North America Insulin Pen Sales by Country
- 7.1.1 North America Insulin Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Insulin Pen Sales by Country (2021-2026)
- 7.1.3 North America Insulin Pen Sales Forecast by Country (2027-2032)
- 7.2 North America Insulin Pen Market Size by Country
- 7.2.1 North America Insulin Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Insulin Pen Market Size by Country (2021-2026)
- 7.2.3 North America Insulin Pen Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Insulin Pen Sales by Country
- 8.1.1 Europe Insulin Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Insulin Pen Sales by Country (2021-2026)
- 8.1.3 Europe Insulin Pen Sales Forecast by Country (2027-2032)
- 8.2 Europe Insulin Pen Market Size by Country
- 8.2.1 Europe Insulin Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Insulin Pen Market Size by Country (2021-2026)
- 8.2.3 Europe Insulin Pen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Insulin Pen Sales by Country
- 9.1.1 Asia-Pacific Insulin Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Insulin Pen Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Insulin Pen Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Insulin Pen Market Size by Country
- 9.2.1 Asia-Pacific Insulin Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Insulin Pen Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Insulin Pen Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Insulin Pen Sales by Country
- 10.1.1 South America Insulin Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Insulin Pen Sales by Country (2021-2026)
- 10.1.3 South America Insulin Pen Sales Forecast by Country (2027-2032)
- 10.2 South America Insulin Pen Market Size by Country
- 10.2.1 South America Insulin Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Insulin Pen Market Size by Country (2021-2026)
- 10.2.3 South America Insulin Pen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Insulin Pen Sales by Country
- 11.1.1 Middle East and Africa Insulin Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Insulin Pen Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Insulin Pen Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Insulin Pen Market Size by Country
- 11.2.1 Middle East and Africa Insulin Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Insulin Pen Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Insulin Pen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Insulin Pen Value Chain Analysis
- 12.1.1 Insulin Pen Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Insulin Pen Production Mode & Process
- 12.2 Insulin Pen Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Insulin Pen Distributors
- 12.2.3 Insulin Pen Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst